Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Article Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Team
    • Feedback
    • Reprints
    • Impact Factor
    • Editorial Fellowship Application Process
  • ASN Kidney News
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Article Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Team
    • Feedback
    • Reprints
    • Impact Factor
    • Editorial Fellowship Application Process
  • ASN Kidney News
  • Follow JASN on Twitter
  • Visit ASN on Facebook
  • Follow JASN on RSS
  • Community Forum

About the Cover

August 2016; Volume 27,Issue 8

Cover image

On the cover: Dual color fluorescence microscopy of primary murine podocytes treated with doxorubicin (ADR) or vehicle (Con) illustrating apoptosis, marked by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL, green); Nrf2 antioxidant response, shown by Nrf2 (green) nuclear translocation; and disruption of actin cytoskeleton integrity, characterized by disorganization of filamentous actin (F-actin) stained with rhodamine phalloidin (red). Cells were counterstained with propidium iodide (PI, red) or 4′,6-diamidino-2-phenylindole (DAPI, blue). The arrow indicates Nrf2 nuclear accumulation. The arrowhead indicates nuclear fragmentation in cells without Nrf2 nuclear accumulation following doxorubicin exposure, suggestive of cellular apoptosis. Rujun Gong, Rhode Island Hospital, Brown Medical School, Providence, Rhode Island

Back to top
PreviousNext

In this issue

Journal of the American Society of Nephrology: 27 (8)
Journal of the American Society of Nephrology
Vol. 27, Issue 8
August 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author

Issue highlights

  • MicroRNA-21 Aggravates Cyst Growth in a Model of Polycystic Kidney Disease
  • Severity and Frequency of Proximal Tubule Injury Determines Renal Prognosis
  • A Randomized Study Comparing Parathyroidectomy with Cinacalcet for Treating Hypercalcemia in Kidney Allograft Recipients with Hyperparathyroidism
  • Increased Synthesis of Liver Erythropoietin with CKD
Sign up for alerts
View Selected Citations (0)

Jump to

  • This Month’s Highlights
  • Up Front Matters
    • Editorials
    • Brief Reviews
    • Special Article
  • Brief Communications
  • Basic Research
  • Clinical Epidemiology
  • Clinical Research
  • Meta-Analysis
  • Most Read
Loading
  • Roxadustat for Treating Anemia in Patients with CKD Not on Dialysis: Results from a Randomized Phase 3 Study
  • A Novel Soluble ACE2 Variant with Prolonged Duration of Action Neutralizes SARS-CoV-2 Infection in Human Kidney Organoids
  • Remdesivir in Patients with Acute or Chronic Kidney Disease and COVID-19
  • Caution in Identifying Coronaviruses by Electron Microscopy
  • AKI in Hospitalized Patients with COVID-19
More...

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Annual Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • Editorial Fellowship Program
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • JASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About JASN
  • JASN Email Alerts
  • JASN Key Impact Information
  • JASN Podcasts
  • JASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe

© 2021 American Society of Nephrology

Print ISSN - 1046-6673 Online ISSN - 1533-3450

Powered by HighWire